Arrowhead Pharmaceuticals Inc Analyst and Investor Event Transcript
Good morning, and welcome to the Arrowhead Pharmaceuticals Cardiometabolic Virtual Investor Event. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Arrowhead website following the conclusion of the event.
I'd now like to turn the call over to Vince Anzalone, Vice President of Finance and Investor Relations at Arrowhead Pharmaceuticals. Please go ahead, Vince.
Thanks so much, Tara. And thanks, everyone, for joining us today. We're here to talk about our cardiometabolic pipeline and some exciting new data we have.
Go ahead in next slide, please. I'm Vince Anzalone, Head of Investor Relations for the company.
Next slide, please. And just reminding everybody that we will be making forward-looking statements on today's call. So please refer to our SEC filings for risk factors.
Next slide, please. Okay. So here is the general flow of today. I'll give some opening statements. Dr. Rosenson will talk
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |